These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In search of an ideal biomarker for nonalcoholic fatty liver disease. Bambha K; Yee HF Am J Gastroenterol; 2008 Jun; 103(6):1380-2. PubMed ID: 18510615 [No Abstract] [Full Text] [Related]
24. [Is there is association between hepatitis C virus and diabetes?]. Wolff C; Moñoz S; Raddatz V Medicina (B Aires); 1999; 59(3):315-6. PubMed ID: 10451579 [No Abstract] [Full Text] [Related]
25. Is type II diabetes another extrahepatic manifestation of HCV infection? Mason A; Nair S Am J Gastroenterol; 2003 Feb; 98(2):243-6. PubMed ID: 12591036 [No Abstract] [Full Text] [Related]
26. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Cusi K Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374 [TBL] [Abstract][Full Text] [Related]
27. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Lecube A; Hernández C; Genescà J; Simó R Diabetes Care; 2006 May; 29(5):1140-9. PubMed ID: 16644655 [No Abstract] [Full Text] [Related]
28. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. Pagadala M; Zein CO; McCullough AJ Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C and diabetes: the inevitable coincidence? Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Prashanth M; Ganesh HK; Vima MV; John M; Bandgar T; Joshi SR; Shah SR; Rathi PM; Joshi AS; Thakkar H; Menon PS; Shah NS J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648 [TBL] [Abstract][Full Text] [Related]
31. [Influence of habitual drinking and viral hepatitis type C in the progression of liver cirrhosis]. Horie Y; Yamagishi Y; Kikuchi M; Saito H; Kato S; Ishii H; Hibi T Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Feb; 44(1):38-42. PubMed ID: 19348160 [TBL] [Abstract][Full Text] [Related]
32. The treatment conundrum of neonatal hemochromatosis. Ekong U Pediatr Transplant; 2007 Jun; 11(4):347-8. PubMed ID: 17493212 [No Abstract] [Full Text] [Related]
33. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Choi SY; Kim D; Kim HJ; Kang JH; Chung SJ; Park MJ; Kim YS; Kim CH; Choi SH; Kim W; Kim YJ; Yoon JH; Lee HS; Cho SH; Sung MW; Oh BH Am J Gastroenterol; 2009 Aug; 104(8):1953-60. PubMed ID: 19491838 [TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Petta S; Muratore C; Craxì A Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251 [TBL] [Abstract][Full Text] [Related]
36. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [TBL] [Abstract][Full Text] [Related]
37. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Wang CS; Yao WJ; Chang TT; Wang ST; Chou P Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812 [TBL] [Abstract][Full Text] [Related]
38. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Brzozowska MM; Ostapowicz G; Weltman MD J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335 [TBL] [Abstract][Full Text] [Related]
39. NASH and HCC. Page JM; Harrison SA Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310 [TBL] [Abstract][Full Text] [Related]